Categories: India

UPDATE 2-CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis

(Adds analyst comment, share moves, and background in paragraphs 3, 8-11) By Rajasik Mukherjee Oct 5 (Reuters) – Australia's CSL said on Monday it had entered into an agreement with Swiss drugmaker

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Indianews Syndication

Recent Posts

France's Schneider Electric nears $20 billion deal to acquire US software group PTC, source says

By Sabrina Valle Oct 4 (Reuters) - France's Schneider Electric is nearing a deal to…

39 seconds ago

OpenAI's Altman says AI benefits warrant accepting some risks

Oct 4 (Reuters) - OpenAI Chief Executive Sam Altman said the benefits of artificial intelligence…

2 minutes ago

BRIEF-Zetrix AI Bhd Clarifies News Article

Oct 5 (Reuters) - Zetrix AI Bhd: * CLARIFICATION ON NEWS ARTICLE APPEARING IN ONLINE…

7 minutes ago

ITHACA ENERGY: STRATEGIC ACQUISITION OF OFFSHORE CANADA ASSETS FROM SUNCOR

ITHACA ENERGY: STRATEGIC ACQUISITION OF OFFSHORE CANADA ASSETS FROM SUNCOR (The article has been published…

11 minutes ago

Revolut's rise to become Europe's $115 billion big bank rival

By Lawrence White and Elizabeth Howcroft LONDON, Oct 4 (Reuters) - Revolut has risen to…

12 minutes ago

Jackson Chourio walk-off single gives Brewers 2-0 NLDS lead on Padres

MILWAUKEE -- Jackson Chourio singled in two runs with the bases loaded and two outs…

18 minutes ago